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Hypertension is a major risk factor for cardiovascular
events and mortality (1-4). Hypertension occurs in 69%
of individuals with first myocardial infarction (5), 77% of
individuals with first stroke (5), 74% of individuals with heart
failure (5), and 60% of individuals with peripheral arterial
disease (6). Hypertension has been diagnosed if the systolic
blood pressure is 140 mmHg or higher or if the diastolic
blood pressure is 90 mmHg or higher (1-4). However, on the
basis of data from the Systolic Blood Pressure Intervention
Trial (SPRINT) (7,8) and a meta-analysis of prospective
studies showing the impact of baseline prehypertension on
cardiovascular events and all-cause mortality in the general
population (9), this author considers hypertension to be
either a systolic blood pressure of 130 mmHg or higher or a
diastolic blood pressure of 80 mmHg or higher.
Pseudohypertension is a falsely increased systolic blood
pressure caused by markedly atherosclerotic arteries which
do not collapse during inflation of the blood pressure
cuff (2,10). Pseudohypertension should be suspected in
older persons with refractory hypertension, no target
organ damage or cardiovascular disease, and symptoms
of overmedication (2). Diagnosis of pseudohypertension
should be confirmed by direct intra-arterial measurement of
blood pressure (11).
White coat hypertension is diagnosed if a patient not
receiving antihypertensive medication has a persistently
high office blood pressure with a normal; ambulatory
blood pressure or home blood pressure (1-3,12). Masked
hypertension is diagnosed if the patient has a normal office
blood pressure measurement but increased ambulatory
blood pressure monitoring or home blood pressure
measurements that are consistently increased (13).
Measurement of blood pressure is very important in the
diagnosis and treatment of hypertension. This editorial will
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discuss the appropriate measurement of blood pressure.
Hypertension is diagnosed if the blood pressure
is elevated on at least three different blood pressure
measurements taken on two or more office visits (1,2). The
blood pressure should be taken after the patient is sitting
comfortably for at least 5 minutes, with the back supported,
feet on the floor, arm supported in the horizontal position
on a desk or table, with the middle of the blood pressure
cuff on the patient’s upper arm at the level of the right
atrium (the midpoint of the sternum) (2,14). The correct
blood pressure cuff size should be used so that the bladder
encircles at least 80% of the upper arm circumference (2).
The blood pressure device should be validated periodically.
If the blood pressure is being taken with a mercury
sphygmomanometer, the cuff pressure should be deflated
2 mmHg per second with the systolic blood pressure
recorded at the onset of the first Korotkoff sound and the
diastolic blood pressure recorded when all Korotkoff sounds
disappear. For manual determination of blood pressure,
estimate the systolic blood pressure when the radial pulse is
obliterated and inflate the cuff 20 to 30 mmHg above this
level for an auscultatory measurement of the blood pressure.
The patient must avoid smoking, drinking a caffeine
beverage, and exercising for at least 30 minutes before the
blood pressure is measured. The patient should empty
his or her urinary bladder before the blood pressure is
measured. Neither the patient nor the person measuring
the blood pressure should talk during the procedure. All
clothing covering the location of cuff placement should be
removed.
The blood pressure also should be measured with the
person standing for 1 to 3 minutes to evaluate for postural
hypotension or hypertension (2,15,16). Older patients
should also be evaluated for postprandial hypotension,
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which is especially common in frail older patients taking
multiple antihypertensive and psychotropic drugs (2,17).
During the initial blood pressure visit, the blood pressure
should be measured in both arms with the arm with the
highest blood pressure used for future monitoring of the
blood pressure (2,18).
Measurement of blood pressure by use of a mercury
sphygmomanometer has given way to use of oscillometric
devices which use a sensor to detect oscillations in pulsatile
blood volume during cuff inflation and deflation. Blood
pressure is indirectly calculated from maximum amplitude
algorithms using population-based data. Only automated
devices with a validated measurement protocol should
be used. The SPRINT trial measured blood pressure
during office visits with the patient sitting in a quiet room
after 5 minutes of quiet rest with the use of an automated
blood pressure measurement system (Model 907, Omron
Healthcare) (7,8). No other person was in the room during
blood pressure measurement to avoid the white coat effect.
Dose adjustment of medications was based on a mean of
three blood pressure measurements. This method of blood
pressure measurement is the most accurate.
Self-monitoring of blood pressure at home is very helpful
in the diagnosis and management of hypertension (2,19,20).
At 1-year follow-up of 450 patients with hypertension at
high risk of cardiovascular disease, compared with a control
group, self-monitoring of blood pressure with self-titration
of antihypertensive medication reduced the blood pressure
8.8/3.1 mmHg (19).
Ambulatory blood pressure monitoring is a better
predictor of cardiovascular risk than office blood pressure
measurements (2,21-23). A meta-analysis of 7,030 persons
in four populations showed at a median of 9.5 years of
follow-up that 10 to 20 hours of daytime ambulatory
blood pressure monitoring predicted cardiovascular events
better than conventional blood pressure monitoring (22).
Cardiovascular risk increased from a normal blood pressure
over white coat and masked hypertension to sustained
hypertension (22). A meta-analysis of nine cohorts
including 13,844 patients with hypertension showed that
9-time systolic blood pressure independently predicted
cardiovascular events better than clinic systolic blood
pressure and daytime systolic blood pressure (23).
The 2016 Canadian Hypertension Education Program
Guideline from Hypertension Canada recommends
the use of unattended automated office blood pressure
measurements with a 5-minute rest period as performed
in the SPRINT trial (7,8) in addition to home blood
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pressure measurement and ambulatory blood pressure
measurement (24,25). This author concurs with this
recommendation.
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